Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22171 | 391 | 31.5 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
429 | 3 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 27734 |
1124 | 2 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 9675 |
22171 | 1 | MESOTHERAPY//INJECTION LIPOLYSIS//LIPODISSOLVE | 391 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MESOTHERAPY | authKW | 999590 | 6% | 53% | 24 |
2 | INJECTION LIPOLYSIS | authKW | 787453 | 3% | 92% | 11 |
3 | LIPODISSOLVE | authKW | 555339 | 2% | 89% | 8 |
4 | POLYENYLPHOSPHATIDYLCHOLINE | authKW | 449964 | 3% | 52% | 11 |
5 | SAFFLOWER PHOSPHOLIPID | authKW | 390474 | 1% | 100% | 5 |
6 | ATX 101 | authKW | 278907 | 1% | 71% | 5 |
7 | UDCA LPE | authKW | 234284 | 1% | 100% | 3 |
8 | SUBMENTAL FAT | authKW | 178499 | 1% | 57% | 4 |
9 | ESSENTIAL PHOSPHOLIPIDS | authKW | 177483 | 1% | 45% | 5 |
10 | EICOSAPENTAENOIC ACID ENRICHED PHOSPHATIDYLCHOLINE | authKW | 156189 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 1979 | 17% | 0% | 68 |
2 | Nutrition & Dietetics | 1831 | 18% | 0% | 72 |
3 | Surgery | 193 | 14% | 0% | 54 |
4 | Food Science & Technology | 129 | 8% | 0% | 30 |
5 | Peripheral Vascular Diseases | 87 | 5% | 0% | 20 |
6 | Pharmacology & Pharmacy | 73 | 10% | 0% | 41 |
7 | Substance Abuse | 61 | 2% | 0% | 8 |
8 | Medicine, General & Internal | 55 | 7% | 0% | 28 |
9 | Integrative & Complementary Medicine | 52 | 2% | 0% | 6 |
10 | Gastroenterology & Hepatology | 46 | 4% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GLOBAL CLIN DEV DERMATOL | 140568 | 1% | 60% | 3 |
2 | NUTR FOOD SCI URBAN PUBL HLTH PROGRAM | 117139 | 1% | 50% | 3 |
3 | INTERNAL MED GASTROENTEROL HEPATOL 4 | 96111 | 1% | 31% | 4 |
4 | BIO FINE CHEM DEV | 78095 | 0% | 100% | 1 |
5 | CHAIR NERVOUS DIS NEUROSURG MED GENET | 78095 | 0% | 100% | 1 |
6 | CLIN SERV AESTHET MED | 78095 | 0% | 100% | 1 |
7 | GYEONGJU ORIENTAL HOSP | 78095 | 0% | 100% | 1 |
8 | HOME ECON AOBA KU | 78095 | 0% | 100% | 1 |
9 | INRACARMEN INSERM U1060UMR1397 | 78095 | 0% | 100% | 1 |
10 | ITALIAN SOC MESOTHER Y | 78095 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY | 5023 | 3% | 0% | 13 |
2 | DERMATOLOGIC SURGERY | 4803 | 4% | 0% | 16 |
3 | AESTHETIC PLASTIC SURGERY | 2149 | 2% | 0% | 9 |
4 | HERZ KREISLAUF | 1992 | 1% | 1% | 5 |
5 | BRITISH JOURNAL ON ALCOHOL AND ALCOHOLISM | 1950 | 0% | 3% | 1 |
6 | CLINICS IN PLASTIC SURGERY | 1797 | 2% | 0% | 7 |
7 | JOURNAL OF DRUGS IN DERMATOLOGY | 1674 | 2% | 0% | 6 |
8 | NUTRITION AND METABOLISM | 1368 | 0% | 2% | 1 |
9 | JOURNAL OF COSMETIC AND LASER THERAPY | 1354 | 1% | 1% | 3 |
10 | INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY | 874 | 1% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MESOTHERAPY | 999590 | 6% | 53% | 24 | Search MESOTHERAPY | Search MESOTHERAPY |
2 | INJECTION LIPOLYSIS | 787453 | 3% | 92% | 11 | Search INJECTION+LIPOLYSIS | Search INJECTION+LIPOLYSIS |
3 | LIPODISSOLVE | 555339 | 2% | 89% | 8 | Search LIPODISSOLVE | Search LIPODISSOLVE |
4 | POLYENYLPHOSPHATIDYLCHOLINE | 449964 | 3% | 52% | 11 | Search POLYENYLPHOSPHATIDYLCHOLINE | Search POLYENYLPHOSPHATIDYLCHOLINE |
5 | SAFFLOWER PHOSPHOLIPID | 390474 | 1% | 100% | 5 | Search SAFFLOWER+PHOSPHOLIPID | Search SAFFLOWER+PHOSPHOLIPID |
6 | ATX 101 | 278907 | 1% | 71% | 5 | Search ATX+101 | Search ATX+101 |
7 | UDCA LPE | 234284 | 1% | 100% | 3 | Search UDCA+LPE | Search UDCA+LPE |
8 | SUBMENTAL FAT | 178499 | 1% | 57% | 4 | Search SUBMENTAL+FAT | Search SUBMENTAL+FAT |
9 | ESSENTIAL PHOSPHOLIPIDS | 177483 | 1% | 45% | 5 | Search ESSENTIAL+PHOSPHOLIPIDS | Search ESSENTIAL+PHOSPHOLIPIDS |
10 | EICOSAPENTAENOIC ACID ENRICHED PHOSPHATIDYLCHOLINE | 156189 | 1% | 100% | 2 | Search EICOSAPENTAENOIC+ACID+ENRICHED+PHOSPHATIDYLCHOLINE | Search EICOSAPENTAENOIC+ACID+ENRICHED+PHOSPHATIDYLCHOLINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JAYASINGHE, S , GUILLOT, T , BISSOON, L , GREENWAY, F , (2013) MESOTHERAPY FOR LOCAL FAT REDUCTION.OBESITY REVIEWS. VOL. 14. ISSUE 10. P. 780-791 | 37 | 65% | 5 |
2 | GUNDERMANN, KJ , KUENKER, A , KUNTZ, E , DROZDZIK, M , (2011) ACTIVITY OF ESSENTIAL PHOSPHOLIPIDS (EPL) FROM SOYBEAN IN LIVER DISEASES.PHARMACOLOGICAL REPORTS. VOL. 63. ISSUE 3. P. 643 -659 | 43 | 51% | 17 |
3 | WOLLINA, U , GOLDMAN, A , (2015) ATX-101 FOR REDUCTION OF SUBMENTAL FAT.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 16. ISSUE 5. P. 755 -762 | 23 | 72% | 7 |
4 | CHEN, DLK , COHEN, JL , GREEN, JB , (2015) INJECTABLE AGENTS AFFECTING SUBCUTANEOUS FATS.SEMINARS IN CUTANEOUS MEDICINE AND SURGERY. VOL. 34. ISSUE 3. P. 134 -137 | 25 | 71% | 0 |
5 | HOFFMANN, K , (2010) INJECTION LIPOLYSIS.HAUTARZT. VOL. 61. ISSUE 10. P. 847 -+ | 19 | 100% | 2 |
6 | ROTUNDA, AM , (2009) INJECTABLE TREATMENTS FOR ADIPOSE TISSUE: TERMINOLOGY, MECHANISM, AND TISSUE INTERACTION.LASERS IN SURGERY AND MEDICINE. VOL. 41. ISSUE 10. P. 714-720 | 21 | 75% | 23 |
7 | RAUSO, R , SALTI, G , (2015) A CE-MARKED DRUG USED FOR LOCALIZED ADIPOSITY REDUCTION: A 4-YEAR EXPERIENCE.AESTHETIC SURGERY JOURNAL. VOL. 35. ISSUE 7. P. 850 -857 | 14 | 100% | 1 |
8 | HUBNER, NF , HORCH, RE , POLYKANDRIOTIS, E , RAU, TT , DRAGU, A , (2014) A HISTOPATHOLOGIC AND IMMUNOHISTOCHEMICAL STUDY ON LIQUIFICATION OF HUMAN ADIPOSE TISSUE EX VIVO.AESTHETIC PLASTIC SURGERY. VOL. 38. ISSUE 5. P. 976 -984 | 20 | 71% | 2 |
9 | HERREROS, FOC , DE MORAES, AM , VELHO, PENF , (2011) MESOTHERAPY: A BIBLIOGRAPHICAL REVIEW.ANAIS BRASILEIROS DE DERMATOLOGIA. VOL. 86. ISSUE 1. P. 91-96 | 23 | 68% | 0 |
10 | MATARASSO, A , PFEIFER, TM , (2009) MESOTHERAPY AND INJECTION LIPOLYSIS.CLINICS IN PLASTIC SURGERY. VOL. 36. ISSUE 2. P. 181-+ | 20 | 69% | 13 |
Classes with closest relation at Level 1 |